Abd-Elmawla MA, ElMonier AA, Gad ES, Khidr HY, Azzam MA (2024a) Implication of Let7b/AhR/ARNT/HMGB1/RAGE cascade in neuroplasticity disturbances induced by glucocorticoids and the promising reversible effect of 3, 3 diindolymethane: Bidirectional crosstalk of Aryl hydrocarbon receptors. Biochemical Pharmacology: 116692

Abd-Elmawla MA, Elsamanoudie NM, Ismail MF, Hammam OA, Hekmat M (2024b) The interplay of TapSAKI and NEAT-1 as potential modulators in gentamicin-induced acute kidney injury via orchestrating miR-22-3p/TLR4/MyD88/NF-қB/IL-1 β milieu: novel therapeutic approach of Betanin. Int Immunopharmacol 143:113577

Article  CAS  PubMed  Google Scholar 

Ahani M, Ghaderian SMH, Azma MM, Kamali K, Gargari BN, Vojdani S (2022) Association of STAT3, PTPRT, TNK2-AS1, LINC-ROR genes expression level with prostate Cancer and Benign Prostatic Hyperplasia. Int J Cancer Manage 15

Ahel J, Hudorović N, Vičić-Hudorović V, Nikles H (2019) Tgf-beta in the natural history of prostate cancer. Acta Clin Croatica 58:128–138

Google Scholar 

Al Aameri RF, Sheth S, Alanisi EM, Borse V, Mukherjea D, Rybak LP, Ramkumar V (2017a) Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: reversal by resveratrol. PLoS ONE 12:e0177198

Article  PubMed  PubMed Central  Google Scholar 

Al Aameri RFH, Sheth S, Alanisi EMA, Borse V, Mukherjea D, Rybak LP, Ramkumar V (2017b) Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: reversal by resveratrol. PLoS ONE 12:e0177198

Article  PubMed  PubMed Central  Google Scholar 

Amado NG, Predes D, Moreno MM, Carvalho IO, Mendes FA, Abreu JG (2014) Flavonoids and Wnt/β-catenin signaling: potential role in colorectal cancer therapies. Int J Mol Sci 15:12094–12106

Article  PubMed  PubMed Central  Google Scholar 

An C, Wang I, Li X, Xia R, Deng F (2022) Long non-coding RNA in prostate cancer. Am J Clin Exp Urol 10:170–179

PubMed  PubMed Central  Google Scholar 

Angeles AK, Heckmann D, Flosdorf N, Duensing S, Sültmann H (2020) The ERG-regulated LINC00920 promotes prostate cancer cell survival via the 14-3-3ϵ–FOXO pathway. Mol Cancer Res 18:1545–1559

Article  CAS  PubMed  Google Scholar 

Anil P, Ghosh Dastidar S, Banerjee S (2022) Unravelling the role of long non-coding RNAs in prostate carcinoma. Adv Cancer Biology - Metastasis 6:100067

Article  CAS  Google Scholar 

Arun G, Diermeier SD, Spector DL (2018) Therapeutic targeting of long non-coding RNAs in Cancer. Trends Mol Med 24:257–277

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh M, Aghamiri S, Tan SC, Zarrabi A, Sharifi E, Rabiee N, Kadumudi FB, Pirouz AD, Delfi M, Byrappa K (2022a) Nanotechnological approaches in prostate cancer therapy: integration of engineering and biology. Nano Today 45:101532

Article  CAS  Google Scholar 

Ashrafizadeh M, Paskeh MDA, Mirzaei S, Gholami MH, Zarrabi A, Hashemi F, Hushmandi K, Hashemi M, Nabavi N, Crea F, Ren J, Klionsky DJ, Kumar AP, Wang Y (2022b) Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. J Exp Clin Cancer Res 41:105

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh M, Zhang W, Tian Y, Sethi G, Zhang X, Qiu A (2024) Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation. Cancer Metastasis Rev 43:229–260

Article  CAS  PubMed  Google Scholar 

Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Grönberg H, Luo J, Visakorpi T, Rubin MA (2013) The mutational landscape of prostate cancer. Eur Urol 64:567–576

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and Cancer: a New Paradigm. Cancer Res 77:3965–3981

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bo S, Lai J, Lin H, Luo X, Zeng Y, Du T (2021) Purpurin, a anthraquinone induces ROS-mediated A549 lung cancer cell apoptosis via inhibition of PI3K/AKT and proliferation. J Pharm Pharmacol 73:1101–1108

Article  PubMed  Google Scholar 

Bu T, Li L, Tian J (2023) Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the wnt signaling pathway. Front Pharmacol 14:1269233

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai Q, Dozmorov M, Oh Y (2020) IGFBP-3/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer. Cells 9:1261

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147:358–369

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cham J, Venkateswaran AR, Bhangoo M (2021) Targeting the PI3K-AKT-mTOR pathway in Castration resistant prostate Cancer: a review article. Clin Genitourin Cancer 19:563. e561-563.e567

Article  Google Scholar 

Chen SJ, Yao XD, Peng BO, Xu YF, Wang GC, Huang J, Liu M, Zheng JH (2016) Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9. Experimental Therapeutic Med 11:1243–1248

Article  CAS  Google Scholar 

Chen J, Wang F, Xu H, Xu L, Chen D, Wang J, Huang S, Wen Y, Fang L (2020) Long non-coding RNA SNHG1 regulates the Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell. Front Oncol 10:552907

Article  PubMed  PubMed Central  Google Scholar 

Chen J-L, Yang S-Y, Zhang J-H, Qiu M-L, Li Y-L, Wang J-H, Shao M, Lu J-X, Zhang Y-B, Wang G-C (2024) Novel filicinic acid-based meroterpenoids with antiproliferative activity against prostate cancer PC-3 cells from Dryopteris wallichiana

Chinison J, Aguilar JS, Avalos A, Huang Y, Wang Z, Cameron DJ, Hao J (2016) Triptonide effectively inhibits Wnt/β-catenin signaling via C-terminal transactivation domain of β-catenin. Sci Rep 6:32779

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cordover E, Minden A, Lehman S, Zhao O (2020) Signaling pathways downstream to receptor tyrosine kinases: targets for cancer treatment. J Cancer Metastasis Treat 6:45

CAS  Google Scholar 

Cuesta C, Arévalo-Alameda C, Castellano E (2021) The importance of being PI3K in the RAS signaling network. Genes 12:1094

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Z, Gao H, Yan N, Dai Y, Wang H, Wang M, Wang J, Zhang D, Sun P, Qi T (2021) LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis. Aging 13:12113

Article  PubMed  PubMed Central  Google Scholar 

Deep G, Gangar SC, Agarwal C, Agarwal R (2011) Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res 4:1222–1232

Article  CAS  Google Scholar 

Degirmenci U, Wang M, Hu J (2020) Targeting aberrant RAS/RAF/MEK/ERK signaling for cancer therapy. Cells 9:198

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng H, Zhu B, Dong Z, Jiang H, Zhao X, Wu S (2021) Mir-214-5p targeted by LncRNA DANCR mediates TGF-β signaling pathway to accelerate proliferation, migration and inhibit apoptosis of prostate cancer cells. Am J Translational Res 13:2224

CAS  Google Scholar 

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J, Guigó R (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775–1789

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhar S, Hicks C, Levenson AS (2011) Resveratrol and prostate cancer: promising role for microRNAs. Mol Nutr Food Res 55:1219–1229

Article  CAS  PubMed  Google Scholar 

Diaz-Laviada I (2010) Effect of capsaicin on prostate cancer cells. Future Oncol 6:1545–1550

Articl